Click on the title of each presentation for a pdf of the slides.

8:00 – 8:15    Welcome and Introductions               

Dr. Richard Hodes, NIA; Ms. Juli Staiano, Foundation for NIH; Dr. Susan Molchan, NIA

8:15-8:45    ADNI – Background, Objectives, Organization, and Progress           

Dr. Michael Weiner, University of California, San Francisco/ADNI Principal Investigator

8:45-9:00    ADNI and the NIH Roadmap for Medical Research/Blueprint for Neuroscience Research      

Dr. Hodes, NIA

9:00-9:15    The Biomarkers Consortium:  Facilitating Public-Private Partnerships   

Dr. C. Anthony Altar, Foundation for NIH
                                       
9:15-10:15    FDA’s Critical Path to New Medical Products; Biomarkers in Drug Development and Diagnosis/Importance of Natural History Data

Dr. Janet Woodcock, FDA
           
10:30-11:00    Industry Perspective: Assessing the Relationship Between Biomarker Changes and Clinical Use in Clinical Trials

Dr. Eric Siemers, Eli Lilly/ADNI Industry Scientific Advisory Board
   
11:00-11:30     FDA Perspective: Assessing the Relationship Between Biomarker Changes and Clinical
Use in Clinical Trials       

Dr. Rusty Katz, FDA

11:30-12:00    Questions/Discussion                           

Dr. Bill Potter, Merck/ADNI Industry Scientific Advisory Board (Discussion leader)

1:00-1:30    An Example/Scenario Using a Drug Targeting Amyloid       

Dr. David Holtzman, Washington University

1:30-1:50    ADNI: Key Questions, Data Access and Analyses    

Dr. Laurel Beckett, University of California, Davis/ADNI Statistics Core

1:50-2:10    ADNI: Informatics, Databasing and Analysis       

Dr. Art Toga, University of California, Los Angeles/ADNI Informatics Core

2:10-2:30    ADNI Biomarker Core

Dr. Les Shaw, University of Pennsylvania

2:30-3:00    Standards for Imaging Biomarkers                   

Dr. George Mills, Parexel (former Director, Division of Medical Imaging, FDA)

3:00-3:20    MRI in ADNI: Lessons Learned   

Dr. Matthew Bernstein, Mayo Clinic/ADNI MRI Neuroimaging Core

3:20-3:40    PET in ADNI: Lessons Learned   

Dr. Bill Jagust, University of California, Berkeley/ADNI PET Neuroimaging Core

3:40-4:10    Questions/Discussion          

Dr. Larry Clarke, NCI/NIBIB (Discussion leader)

4:10-4:25    Building on the Success of ADNI:  International Efforts           

Dr. Maria Carrillo, Alzheimer’s Association

4:25-4:40    Getting the Most Out of ADNI: Where Do We Go from Here?               

Dr. Weiner; Dr. Siemers